MYM Nutraceuticals, Inc. (OTC: MYMMF) Rob Gietl, CEO Interview. Medicinal cannabis company projects “$3 billion revenues in 2020”.

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

 

MYM Nutraceuticals, Inc. (CSE: MYM) (OTC: MYMMF) CEO Interview with Rob Gietl, discussing progress toward the company’s goal of becoming a vertically integrated player in the medicinal cannabis space, with a multi-national footprint. Rob addresses the recent CDN$50 million shelf offering, cannabis growing facilities coming online, starting in Q1 2019, and his objective of “$3 billion revenues in 2020”.

 

 

Investor Presentation

MYM Nutraceutical